Nk cell-mediated cytotoxicity modulation by A2; adenosine receptor agonist in different mammalian species

Folia Microbiologica

Volumn 54, Issue 4, 2009, Pages 364-368

  Kuldova M ^a   Svoboda, J ^a   Kovaru F ^b   Vannucci, L ^a   Kovaru H ^c   Fiserova A ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; DRUG DERIVATIVE; N CYCLOPROPYL ADENOSINE 5' CARBOXAMIDE; N-CYCLOPROPYL ADENOSINE-5'-CARBOXAMIDE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CYTOTOXICITY; DRUG EFFECT; FEMALE; GOAT; HUMAN; IMMUNOLOGY; MALE; MOUSE; NATURAL KILLER CELL; NEOPLASM; RAT; RODENT; SWINE; WISTAR RAT;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GOATS; HUMANS; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS; RATS; RATS, WISTAR; RECEPTORS, ADENOSINE A2; RODENTIA; SWINE;

CAPRA HIRCUS; MAMMALIA; RODENTIA; SUIDAE;

EID: 70350388996     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-009-0051-4     Document Type: Article

References (21)

1. Bobek V., Boubelik M., Fiserova A., Luptovcova M., Vannucci L., Kacprzak G., Kolodzej J., Majewski A.M., Hoffman R.M.: Anticoagulant drugs increase natural killer cell activity in lung cancer. Lung Cancer 47, 215-223 (2005).
2. Borovansky J., Horak V., Elleder M., Fortyn K., Smith N.P., Kolb A.M.: Biochemical characterization of a new melanoma model - the minipig MeLiM strain. Melanoma Res. 13, 543-548 (2003).
3. Burnstock G.: The past, present and future of purine nucleotides as signaling molecules. Neuropharmacology 36, 1127-1139 (1997).
4. Cronstein B.N.: Adenosine, an endogenous anti-inflammatory agent. J.Appl.Physiol. 76, 5-13 (1994).
5. 2-dopamine and α-adrenoceptor antagonists in stress induced changes on immune responsiveness of mice. J.Neuroimmunol. 130, 55-65 (2002).
6. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K., Linden J.: International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol.Rev. 53, 527-552 (2001).
7. Haskó G., Linden J., Cronstein B., Pacher P.: Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nature Rev.Drug Discov. 7, 759-770 (2008).
8. 2 cell-surface adenosine receptor. Cell.Immunol. 159, 85-93 (1994).
9. Hoskin D.W., Mader J.S., Furlong S.J., Conrad D.M., Blay J.: Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (review). Internat.J.Oncol. 32, 527-535 (2008).
10. Klinger M., Freissmuth M., Nanoff C.: Adenosine receptors: G protein-mediated signaling and the role of accessory proteins. Cell Signal. 14, 99-108 (2002).
11. Lokshin A., Raskovalova T., Huang X., Zacharia L.C., Jackson E.K., Gorelik E.: Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells. Cancer Res. 66, 7758-7765 (2006).
12. 2a adenosine receptor induction. Biochem.J. 391, 575-580 (2005).
13. Ohta A., Sitkovsky M.: Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916-920 (2001).
14. 2a adenosine receptor protects tumors from antitumor T cells. Proc.Nat.Acad.Sci.USA 103, 13132-13137 (2006).
15. Priebe T., Platsoucas C.D., Nelson J.A.: Adenosine receptors and modulation of natural killer cell activity by purine nucleosides. Cancer Res. 50, 4328-4331 (1990).
16. Raskovalova T., Huang X., Sitkovsky M., Zacharia L.C., Jackson E.K., Gorelik E.: Gs Protein-coupled adenosine receptor signaling and lytic function of activated NK cells. J.Immunol. 175, 4383-4391 (2005).
17. Raskovalova T., Lokshin A., Huang X., Jackson E.K., Gorelik E.: Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2/NKp46-activated NK cells: involvement of protein kinase A isozyme I (PKA I). Immunol.Res. 36, 91-99 (2006).
18. 2a adenosine receptor as a physiological immunosupressor and to engineer inflammation in vivo. Biochem. Pharmacol. 65, 493-501 (2003).
19. 2a receptors. Ann.Rev. Immunol. 22, 657-682 (2004).
20. Trebichavský I., Šplíchal I., Šplíchalová A., Muneta Y., Mori Y.: Systemic and local cytokine response of young piglets to oral infection with Salmonella enterica serotype Typhimurium. Folia Microbiol. 48, 403-407 (2003).
21. Vannucci L., Huggins C.B., Mosca F.: A new experimental model for colorectal carcinogenesis in the rat. J.Environ.Pathol.Toxicol. Oncol. 13, 59-61 (1994).